Skip to main content

dicyclomine

Generic: DICYCLOMINE HYDROCHLORIDE·Brand: BENTYL, BENTYL PRESERVATIVE FREE, Bentyl, DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE)

dicyclomine: sourced relationships with 1 company · 1 FDA decision.

dicyclomine evidence translation

What we can confirm

What it means

Source-backed records connect dicyclomine to NEXS; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could dicyclomine → NEXS affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Dated Pipeline Records (2)
CompanyDated record stage
NEXUS BIOPHARMA INC (NEXS)
Reported 2019-02-01 · Current development: unknownSource
Approved
NEXUS BIOPHARMA INC (NEXS)
Reported 2019-02-01 · Current development: unknownSource
Approved
FDA Decisions1 records
Approval1 INDICATIONS AND USAGE Dicyclomine hydrochloride capsules, USP are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. Dicyclomine hydrochloride capsules, USP are an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome (1)(NEXS)FDA ↗
ANDA206468UNKNOWNStandardOtherInjectable

Frequently asked questions

Which companies have sourced relationships with dicyclomine?

dicyclomine has dated SEC/FDA relationship records for NEXUS BIOPHARMA INC.

What is dicyclomine's latest FDA decision?

The most recent tracked FDA decision for dicyclomine is Approval for 1 INDICATIONS AND USAGE Dicyclomine hydrochloride capsules, USP are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. Dicyclomine hydrochloride capsules, USP are an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome (1), dated February 1, 2019.